nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—melanoma	0.476	1	CbGaD
Sitagliptin—CYP3A4—Temozolomide—melanoma	0.124	0.376	CbGbCtD
Sitagliptin—ABCB1—Dactinomycin—melanoma	0.0751	0.229	CbGbCtD
Sitagliptin—CYP3A4—Vemurafenib—melanoma	0.0677	0.206	CbGbCtD
Sitagliptin—ABCB1—Docetaxel—melanoma	0.0388	0.118	CbGbCtD
Sitagliptin—CYP3A4—Docetaxel—melanoma	0.0232	0.0707	CbGbCtD
Sitagliptin—Neuropathy peripheral—Vemurafenib—melanoma	0.00161	0.00895	CcSEcCtD
Sitagliptin—Neck pain—Carmustine—melanoma	0.00157	0.00874	CcSEcCtD
Sitagliptin—Parosmia—Docetaxel—melanoma	0.00154	0.00855	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Temozolomide—melanoma	0.00152	0.00844	CcSEcCtD
Sitagliptin—Pharyngolaryngeal pain—Docetaxel—melanoma	0.00148	0.00822	CcSEcCtD
Sitagliptin—Laryngeal pain—Docetaxel—melanoma	0.00146	0.00814	CcSEcCtD
Sitagliptin—Oedema peripheral—Vemurafenib—melanoma	0.00145	0.00807	CcSEcCtD
Sitagliptin—Connective tissue disorder—Vemurafenib—melanoma	0.00145	0.00805	CcSEcCtD
Sitagliptin—Erythema multiforme—Vemurafenib—melanoma	0.00139	0.00775	CcSEcCtD
Sitagliptin—Eye disorder—Vemurafenib—melanoma	0.00138	0.00766	CcSEcCtD
Sitagliptin—Cardiac disorder—Vemurafenib—melanoma	0.00137	0.00761	CcSEcCtD
Sitagliptin—Angiopathy—Vemurafenib—melanoma	0.00134	0.00744	CcSEcCtD
Sitagliptin—Mediastinal disorder—Vemurafenib—melanoma	0.00133	0.00739	CcSEcCtD
Sitagliptin—Malnutrition—Vemurafenib—melanoma	0.00128	0.00713	CcSEcCtD
Sitagliptin—Back pain—Vemurafenib—melanoma	0.00124	0.0069	CcSEcCtD
Sitagliptin—Gastroenteritis—Temozolomide—melanoma	0.00123	0.00683	CcSEcCtD
Sitagliptin—Cough—Vemurafenib—melanoma	0.00112	0.00623	CcSEcCtD
Sitagliptin—Arthralgia—Vemurafenib—melanoma	0.00109	0.00607	CcSEcCtD
Sitagliptin—Myalgia—Vemurafenib—melanoma	0.00109	0.00607	CcSEcCtD
Sitagliptin—Face oedema—Carmustine—melanoma	0.00109	0.00605	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00108	0.00603	CcSEcCtD
Sitagliptin—Face oedema—Temozolomide—melanoma	0.00105	0.00585	CcSEcCtD
Sitagliptin—Anaphylactic shock—Vemurafenib—melanoma	0.00105	0.00582	CcSEcCtD
Sitagliptin—Infection—Vemurafenib—melanoma	0.00104	0.00578	CcSEcCtD
Sitagliptin—Nervous system disorder—Vemurafenib—melanoma	0.00103	0.00571	CcSEcCtD
Sitagliptin—Skin disorder—Vemurafenib—melanoma	0.00102	0.00566	CcSEcCtD
Sitagliptin—Pneumonia—Bleomycin—melanoma	0.001	0.00556	CcSEcCtD
Sitagliptin—Breast disorder—Temozolomide—melanoma	0.000983	0.00547	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000954	0.0053	CcSEcCtD
Sitagliptin—Pneumonia—Dactinomycin—melanoma	0.000933	0.00519	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000919	0.00511	CcSEcCtD
Sitagliptin—Decreased appetite—Vemurafenib—melanoma	0.00091	0.00506	CcSEcCtD
Sitagliptin—Bronchitis—Temozolomide—melanoma	0.000905	0.00503	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000904	0.00503	CcSEcCtD
Sitagliptin—Fatigue—Vemurafenib—melanoma	0.000902	0.00502	CcSEcCtD
Sitagliptin—Constipation—Vemurafenib—melanoma	0.000895	0.00498	CcSEcCtD
Sitagliptin—Hypoaesthesia—Bleomycin—melanoma	0.000888	0.00494	CcSEcCtD
Sitagliptin—Hyperglycaemia—Carmustine—melanoma	0.000878	0.00488	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Temozolomide—melanoma	0.000874	0.00486	CcSEcCtD
Sitagliptin—Pneumonia—Carmustine—melanoma	0.000873	0.00486	CcSEcCtD
Sitagliptin—Erectile dysfunction—Temozolomide—melanoma	0.000866	0.00482	CcSEcCtD
Sitagliptin—Depression—Carmustine—melanoma	0.000865	0.00481	CcSEcCtD
Sitagliptin—Weight increased—Temozolomide—melanoma	0.000856	0.00476	CcSEcCtD
Sitagliptin—Renal failure—Carmustine—melanoma	0.000853	0.00475	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Carmustine—melanoma	0.000851	0.00473	CcSEcCtD
Sitagliptin—Hyperglycaemia—Temozolomide—melanoma	0.000848	0.00472	CcSEcCtD
Sitagliptin—Urinary tract infection—Carmustine—melanoma	0.000844	0.00469	CcSEcCtD
Sitagliptin—Pneumonia—Temozolomide—melanoma	0.000844	0.00469	CcSEcCtD
Sitagliptin—Infestation—Temozolomide—melanoma	0.000839	0.00467	CcSEcCtD
Sitagliptin—Infestation NOS—Temozolomide—melanoma	0.000839	0.00467	CcSEcCtD
Sitagliptin—Depression—Temozolomide—melanoma	0.000836	0.00465	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000831	0.00463	CcSEcCtD
Sitagliptin—Pharyngitis—Dactinomycin—melanoma	0.000826	0.0046	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Temozolomide—melanoma	0.000822	0.00457	CcSEcCtD
Sitagliptin—Urinary tract infection—Temozolomide—melanoma	0.000815	0.00454	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Temozolomide—melanoma	0.000793	0.00441	CcSEcCtD
Sitagliptin—Erythema multiforme—Dactinomycin—melanoma	0.000787	0.00438	CcSEcCtD
Sitagliptin—Sinusitis—Temozolomide—melanoma	0.000787	0.00438	CcSEcCtD
Sitagliptin—Hypoaesthesia—Carmustine—melanoma	0.000775	0.00431	CcSEcCtD
Sitagliptin—Hypersensitivity—Vemurafenib—melanoma	0.000771	0.00429	CcSEcCtD
Sitagliptin—Oedema peripheral—Carmustine—melanoma	0.000767	0.00427	CcSEcCtD
Sitagliptin—Connective tissue disorder—Carmustine—melanoma	0.000766	0.00426	CcSEcCtD
Sitagliptin—Renal impairment—Docetaxel—melanoma	0.00076	0.00423	CcSEcCtD
Sitagliptin—Asthenia—Vemurafenib—melanoma	0.000751	0.00418	CcSEcCtD
Sitagliptin—Hypoaesthesia—Temozolomide—melanoma	0.000749	0.00417	CcSEcCtD
Sitagliptin—Pharyngitis—Temozolomide—melanoma	0.000747	0.00416	CcSEcCtD
Sitagliptin—Urinary tract disorder—Temozolomide—melanoma	0.000744	0.00414	CcSEcCtD
Sitagliptin—Oedema peripheral—Temozolomide—melanoma	0.000742	0.00413	CcSEcCtD
Sitagliptin—Connective tissue disorder—Temozolomide—melanoma	0.00074	0.00412	CcSEcCtD
Sitagliptin—Urethral disorder—Temozolomide—melanoma	0.000738	0.00411	CcSEcCtD
Sitagliptin—Eye disorder—Carmustine—melanoma	0.000728	0.00405	CcSEcCtD
Sitagliptin—Pain in extremity—Docetaxel—melanoma	0.000724	0.00403	CcSEcCtD
Sitagliptin—Ill-defined disorder—Bleomycin—melanoma	0.000721	0.00401	CcSEcCtD
Sitagliptin—Diarrhoea—Vemurafenib—melanoma	0.000716	0.00398	CcSEcCtD
Sitagliptin—Migraine—Docetaxel—melanoma	0.000712	0.00396	CcSEcCtD
Sitagliptin—Erythema multiforme—Temozolomide—melanoma	0.000712	0.00396	CcSEcCtD
Sitagliptin—Eye disorder—Temozolomide—melanoma	0.000704	0.00391	CcSEcCtD
Sitagliptin—Malaise—Bleomycin—melanoma	0.000701	0.0039	CcSEcCtD
Sitagliptin—Cardiac disorder—Temozolomide—melanoma	0.000699	0.00389	CcSEcCtD
Sitagliptin—Dizziness—Vemurafenib—melanoma	0.000692	0.00385	CcSEcCtD
Sitagliptin—Angiopathy—Temozolomide—melanoma	0.000683	0.0038	CcSEcCtD
Sitagliptin—Mental disorder—Carmustine—melanoma	0.000683	0.0038	CcSEcCtD
Sitagliptin—Immune system disorder—Temozolomide—melanoma	0.00068	0.00378	CcSEcCtD
Sitagliptin—Mediastinal disorder—Temozolomide—melanoma	0.000679	0.00377	CcSEcCtD
Sitagliptin—Malnutrition—Carmustine—melanoma	0.000678	0.00377	CcSEcCtD
Sitagliptin—Cough—Bleomycin—melanoma	0.000678	0.00377	CcSEcCtD
Sitagliptin—Ill-defined disorder—Dactinomycin—melanoma	0.000672	0.00374	CcSEcCtD
Sitagliptin—Vomiting—Vemurafenib—melanoma	0.000665	0.0037	CcSEcCtD
Sitagliptin—Myalgia—Bleomycin—melanoma	0.000661	0.00368	CcSEcCtD
Sitagliptin—Abdominal pain upper—Docetaxel—melanoma	0.000661	0.00368	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Docetaxel—melanoma	0.000661	0.00368	CcSEcCtD
Sitagliptin—Rash—Vemurafenib—melanoma	0.00066	0.00367	CcSEcCtD
Sitagliptin—Mental disorder—Temozolomide—melanoma	0.00066	0.00367	CcSEcCtD
Sitagliptin—Dermatitis—Vemurafenib—melanoma	0.000659	0.00367	CcSEcCtD
Sitagliptin—Back pain—Carmustine—melanoma	0.000656	0.00365	CcSEcCtD
Sitagliptin—Headache—Vemurafenib—melanoma	0.000656	0.00365	CcSEcCtD
Sitagliptin—Malnutrition—Temozolomide—melanoma	0.000655	0.00365	CcSEcCtD
Sitagliptin—Breast disorder—Docetaxel—melanoma	0.000654	0.00364	CcSEcCtD
Sitagliptin—Discomfort—Bleomycin—melanoma	0.000654	0.00364	CcSEcCtD
Sitagliptin—Malaise—Dactinomycin—melanoma	0.000653	0.00364	CcSEcCtD
Sitagliptin—Nasopharyngitis—Docetaxel—melanoma	0.000647	0.0036	CcSEcCtD
Sitagliptin—Vision blurred—Carmustine—melanoma	0.000639	0.00356	CcSEcCtD
Sitagliptin—Anaphylactic shock—Bleomycin—melanoma	0.000634	0.00353	CcSEcCtD
Sitagliptin—Back pain—Temozolomide—melanoma	0.000634	0.00353	CcSEcCtD
Sitagliptin—Infection—Bleomycin—melanoma	0.00063	0.0035	CcSEcCtD
Sitagliptin—Nausea—Vemurafenib—melanoma	0.000622	0.00346	CcSEcCtD
Sitagliptin—Vision blurred—Temozolomide—melanoma	0.000618	0.00344	CcSEcCtD
Sitagliptin—Myalgia—Dactinomycin—melanoma	0.000617	0.00343	CcSEcCtD
Sitagliptin—Discomfort—Dactinomycin—melanoma	0.00061	0.00339	CcSEcCtD
Sitagliptin—Ill-defined disorder—Temozolomide—melanoma	0.000608	0.00338	CcSEcCtD
Sitagliptin—Angioedema—Temozolomide—melanoma	0.000599	0.00333	CcSEcCtD
Sitagliptin—Malaise—Temozolomide—melanoma	0.000591	0.00329	CcSEcCtD
Sitagliptin—Vertigo—Temozolomide—melanoma	0.000589	0.00328	CcSEcCtD
Sitagliptin—Infection—Dactinomycin—melanoma	0.000588	0.00327	CcSEcCtD
Sitagliptin—Hypertension—Carmustine—melanoma	0.000586	0.00326	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000578	0.00321	CcSEcCtD
Sitagliptin—Myalgia—Carmustine—melanoma	0.000577	0.00321	CcSEcCtD
Sitagliptin—Anxiety—Carmustine—melanoma	0.000575	0.0032	CcSEcCtD
Sitagliptin—Cough—Temozolomide—melanoma	0.000572	0.00318	CcSEcCtD
Sitagliptin—Weight increased—Docetaxel—melanoma	0.000569	0.00317	CcSEcCtD
Sitagliptin—Hypertension—Temozolomide—melanoma	0.000566	0.00315	CcSEcCtD
Sitagliptin—Pneumonia—Docetaxel—melanoma	0.000561	0.00312	CcSEcCtD
Sitagliptin—Arthralgia—Temozolomide—melanoma	0.000558	0.0031	CcSEcCtD
Sitagliptin—Myalgia—Temozolomide—melanoma	0.000558	0.0031	CcSEcCtD
Sitagliptin—Infestation NOS—Docetaxel—melanoma	0.000558	0.0031	CcSEcCtD
Sitagliptin—Infestation—Docetaxel—melanoma	0.000558	0.0031	CcSEcCtD
Sitagliptin—Anxiety—Temozolomide—melanoma	0.000556	0.00309	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000554	0.00308	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000553	0.00308	CcSEcCtD
Sitagliptin—Discomfort—Temozolomide—melanoma	0.000551	0.00307	CcSEcCtD
Sitagliptin—Decreased appetite—Bleomycin—melanoma	0.000551	0.00307	CcSEcCtD
Sitagliptin—Infection—Carmustine—melanoma	0.00055	0.00306	CcSEcCtD
Sitagliptin—Renal failure—Docetaxel—melanoma	0.000548	0.00305	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Docetaxel—melanoma	0.000547	0.00304	CcSEcCtD
Sitagliptin—Dry mouth—Temozolomide—melanoma	0.000546	0.00304	CcSEcCtD
Sitagliptin—Pain—Bleomycin—melanoma	0.000542	0.00302	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000539	0.003	CcSEcCtD
Sitagliptin—Anaphylactic shock—Temozolomide—melanoma	0.000535	0.00298	CcSEcCtD
Sitagliptin—Infection—Temozolomide—melanoma	0.000531	0.00296	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Docetaxel—melanoma	0.000527	0.00293	CcSEcCtD
Sitagliptin—Nervous system disorder—Temozolomide—melanoma	0.000525	0.00292	CcSEcCtD
Sitagliptin—Feeling abnormal—Bleomycin—melanoma	0.000523	0.00291	CcSEcCtD
Sitagliptin—Skin disorder—Temozolomide—melanoma	0.00052	0.00289	CcSEcCtD
Sitagliptin—Decreased appetite—Dactinomycin—melanoma	0.000514	0.00286	CcSEcCtD
Sitagliptin—Fatigue—Dactinomycin—melanoma	0.00051	0.00284	CcSEcCtD
Sitagliptin—Pain—Dactinomycin—melanoma	0.000506	0.00281	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Carmustine—melanoma	0.000504	0.00281	CcSEcCtD
Sitagliptin—Urticaria—Bleomycin—melanoma	0.000504	0.0028	CcSEcCtD
Sitagliptin—Insomnia—Carmustine—melanoma	0.000501	0.00279	CcSEcCtD
Sitagliptin—Hypoaesthesia—Docetaxel—melanoma	0.000498	0.00277	CcSEcCtD
Sitagliptin—Pharyngitis—Docetaxel—melanoma	0.000497	0.00276	CcSEcCtD
Sitagliptin—Urinary tract disorder—Docetaxel—melanoma	0.000494	0.00275	CcSEcCtD
Sitagliptin—Oedema peripheral—Docetaxel—melanoma	0.000493	0.00274	CcSEcCtD
Sitagliptin—Somnolence—Carmustine—melanoma	0.000492	0.00274	CcSEcCtD
Sitagliptin—Connective tissue disorder—Docetaxel—melanoma	0.000492	0.00274	CcSEcCtD
Sitagliptin—Urethral disorder—Docetaxel—melanoma	0.000491	0.00273	CcSEcCtD
Sitagliptin—Feeling abnormal—Dactinomycin—melanoma	0.000487	0.00271	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000487	0.00271	CcSEcCtD
Sitagliptin—Insomnia—Temozolomide—melanoma	0.000484	0.00269	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dactinomycin—melanoma	0.000484	0.00269	CcSEcCtD
Sitagliptin—Decreased appetite—Carmustine—melanoma	0.000481	0.00268	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Carmustine—melanoma	0.000478	0.00266	CcSEcCtD
Sitagliptin—Somnolence—Temozolomide—melanoma	0.000476	0.00265	CcSEcCtD
Sitagliptin—Erythema multiforme—Docetaxel—melanoma	0.000473	0.00263	CcSEcCtD
Sitagliptin—Constipation—Carmustine—melanoma	0.000473	0.00263	CcSEcCtD
Sitagliptin—Pain—Carmustine—melanoma	0.000473	0.00263	CcSEcCtD
Sitagliptin—Dyspepsia—Temozolomide—melanoma	0.000471	0.00262	CcSEcCtD
Sitagliptin—Eye disorder—Docetaxel—melanoma	0.000468	0.0026	CcSEcCtD
Sitagliptin—Abdominal pain—Dactinomycin—melanoma	0.000467	0.0026	CcSEcCtD
Sitagliptin—Hypersensitivity—Bleomycin—melanoma	0.000467	0.0026	CcSEcCtD
Sitagliptin—Decreased appetite—Temozolomide—melanoma	0.000465	0.00259	CcSEcCtD
Sitagliptin—Cardiac disorder—Docetaxel—melanoma	0.000465	0.00259	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Temozolomide—melanoma	0.000462	0.00257	CcSEcCtD
Sitagliptin—Fatigue—Temozolomide—melanoma	0.000461	0.00257	CcSEcCtD
Sitagliptin—Constipation—Temozolomide—melanoma	0.000457	0.00254	CcSEcCtD
Sitagliptin—Pain—Temozolomide—melanoma	0.000457	0.00254	CcSEcCtD
Sitagliptin—Feeling abnormal—Carmustine—melanoma	0.000456	0.00254	CcSEcCtD
Sitagliptin—Asthenia—Bleomycin—melanoma	0.000455	0.00253	CcSEcCtD
Sitagliptin—Angiopathy—Docetaxel—melanoma	0.000454	0.00253	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Carmustine—melanoma	0.000453	0.00252	CcSEcCtD
Sitagliptin—Immune system disorder—Docetaxel—melanoma	0.000452	0.00252	CcSEcCtD
Sitagliptin—Mediastinal disorder—Docetaxel—melanoma	0.000451	0.00251	CcSEcCtD
Sitagliptin—Feeling abnormal—Temozolomide—melanoma	0.000441	0.00245	CcSEcCtD
Sitagliptin—Mental disorder—Docetaxel—melanoma	0.000439	0.00244	CcSEcCtD
Sitagliptin—Abdominal pain—Carmustine—melanoma	0.000438	0.00243	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Temozolomide—melanoma	0.000437	0.00243	CcSEcCtD
Sitagliptin—Malnutrition—Docetaxel—melanoma	0.000436	0.00242	CcSEcCtD
Sitagliptin—Hypersensitivity—Dactinomycin—melanoma	0.000436	0.00242	CcSEcCtD
Sitagliptin—Urticaria—Temozolomide—melanoma	0.000425	0.00236	CcSEcCtD
Sitagliptin—Asthenia—Dactinomycin—melanoma	0.000424	0.00236	CcSEcCtD
Sitagliptin—Abdominal pain—Temozolomide—melanoma	0.000423	0.00235	CcSEcCtD
Sitagliptin—Back pain—Docetaxel—melanoma	0.000422	0.00235	CcSEcCtD
Sitagliptin—Muscle spasms—Docetaxel—melanoma	0.000419	0.00233	CcSEcCtD
Sitagliptin—Hypersensitivity—Carmustine—melanoma	0.000408	0.00227	CcSEcCtD
Sitagliptin—Diarrhoea—Dactinomycin—melanoma	0.000405	0.00225	CcSEcCtD
Sitagliptin—Vomiting—Bleomycin—melanoma	0.000403	0.00224	CcSEcCtD
Sitagliptin—Rash—Bleomycin—melanoma	0.0004	0.00222	CcSEcCtD
Sitagliptin—Dermatitis—Bleomycin—melanoma	0.000399	0.00222	CcSEcCtD
Sitagliptin—Asthenia—Carmustine—melanoma	0.000397	0.00221	CcSEcCtD
Sitagliptin—Hypersensitivity—Temozolomide—melanoma	0.000394	0.00219	CcSEcCtD
Sitagliptin—Asthenia—Temozolomide—melanoma	0.000384	0.00214	CcSEcCtD
Sitagliptin—Cough—Docetaxel—melanoma	0.00038	0.00212	CcSEcCtD
Sitagliptin—Diarrhoea—Carmustine—melanoma	0.000379	0.00211	CcSEcCtD
Sitagliptin—Nausea—Bleomycin—melanoma	0.000377	0.0021	CcSEcCtD
Sitagliptin—Hypertension—Docetaxel—melanoma	0.000376	0.00209	CcSEcCtD
Sitagliptin—Vomiting—Dactinomycin—melanoma	0.000376	0.00209	CcSEcCtD
Sitagliptin—Rash—Dactinomycin—melanoma	0.000373	0.00207	CcSEcCtD
Sitagliptin—Myalgia—Docetaxel—melanoma	0.000371	0.00206	CcSEcCtD
Sitagliptin—Arthralgia—Docetaxel—melanoma	0.000371	0.00206	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000369	0.00205	CcSEcCtD
Sitagliptin—Dizziness—Carmustine—melanoma	0.000366	0.00204	CcSEcCtD
Sitagliptin—Diarrhoea—Temozolomide—melanoma	0.000366	0.00204	CcSEcCtD
Sitagliptin—Dry mouth—Docetaxel—melanoma	0.000363	0.00202	CcSEcCtD
Sitagliptin—Anaphylactic shock—Docetaxel—melanoma	0.000356	0.00198	CcSEcCtD
Sitagliptin—Dizziness—Temozolomide—melanoma	0.000354	0.00197	CcSEcCtD
Sitagliptin—Infection—Docetaxel—melanoma	0.000353	0.00197	CcSEcCtD
Sitagliptin—Vomiting—Carmustine—melanoma	0.000352	0.00196	CcSEcCtD
Sitagliptin—Nausea—Dactinomycin—melanoma	0.000351	0.00195	CcSEcCtD
Sitagliptin—Rash—Carmustine—melanoma	0.000349	0.00194	CcSEcCtD
Sitagliptin—Nervous system disorder—Docetaxel—melanoma	0.000349	0.00194	CcSEcCtD
Sitagliptin—Dermatitis—Carmustine—melanoma	0.000349	0.00194	CcSEcCtD
Sitagliptin—Headache—Carmustine—melanoma	0.000347	0.00193	CcSEcCtD
Sitagliptin—Skin disorder—Docetaxel—melanoma	0.000346	0.00192	CcSEcCtD
Sitagliptin—Vomiting—Temozolomide—melanoma	0.00034	0.00189	CcSEcCtD
Sitagliptin—Rash—Temozolomide—melanoma	0.000337	0.00188	CcSEcCtD
Sitagliptin—Dermatitis—Temozolomide—melanoma	0.000337	0.00187	CcSEcCtD
Sitagliptin—Headache—Temozolomide—melanoma	0.000335	0.00186	CcSEcCtD
Sitagliptin—Nausea—Carmustine—melanoma	0.000329	0.00183	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000324	0.0018	CcSEcCtD
Sitagliptin—Insomnia—Docetaxel—melanoma	0.000322	0.00179	CcSEcCtD
Sitagliptin—Nausea—Temozolomide—melanoma	0.000318	0.00177	CcSEcCtD
Sitagliptin—Somnolence—Docetaxel—melanoma	0.000316	0.00176	CcSEcCtD
Sitagliptin—Dyspepsia—Docetaxel—melanoma	0.000313	0.00174	CcSEcCtD
Sitagliptin—Decreased appetite—Docetaxel—melanoma	0.000309	0.00172	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Docetaxel—melanoma	0.000307	0.00171	CcSEcCtD
Sitagliptin—Fatigue—Docetaxel—melanoma	0.000307	0.00171	CcSEcCtD
Sitagliptin—Pain—Docetaxel—melanoma	0.000304	0.00169	CcSEcCtD
Sitagliptin—Constipation—Docetaxel—melanoma	0.000304	0.00169	CcSEcCtD
Sitagliptin—Feeling abnormal—Docetaxel—melanoma	0.000293	0.00163	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Docetaxel—melanoma	0.000291	0.00162	CcSEcCtD
Sitagliptin—Abdominal pain—Docetaxel—melanoma	0.000281	0.00156	CcSEcCtD
Sitagliptin—Hypersensitivity—Docetaxel—melanoma	0.000262	0.00146	CcSEcCtD
Sitagliptin—Asthenia—Docetaxel—melanoma	0.000255	0.00142	CcSEcCtD
Sitagliptin—Diarrhoea—Docetaxel—melanoma	0.000243	0.00135	CcSEcCtD
Sitagliptin—Dizziness—Docetaxel—melanoma	0.000235	0.00131	CcSEcCtD
Sitagliptin—Vomiting—Docetaxel—melanoma	0.000226	0.00126	CcSEcCtD
Sitagliptin—Rash—Docetaxel—melanoma	0.000224	0.00125	CcSEcCtD
Sitagliptin—Dermatitis—Docetaxel—melanoma	0.000224	0.00125	CcSEcCtD
Sitagliptin—Headache—Docetaxel—melanoma	0.000223	0.00124	CcSEcCtD
Sitagliptin—Nausea—Docetaxel—melanoma	0.000211	0.00118	CcSEcCtD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	9.56e-05	0.00591	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—CYP1B1—melanoma	9.54e-05	0.00589	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	9.48e-05	0.00586	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	9.44e-05	0.00583	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	9.3e-05	0.00575	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—FOXP3—melanoma	8.61e-05	0.00532	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	8.56e-05	0.00529	CbGpPWpGaD
Sitagliptin—CYP3A4—Irinotecan Pathway—APC—melanoma	8.42e-05	0.0052	CbGpPWpGaD
Sitagliptin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	8.25e-05	0.00509	CbGpPWpGaD
Sitagliptin—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—melanoma	8.14e-05	0.00503	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—AKR1B10—melanoma	8.05e-05	0.00497	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	7.94e-05	0.00491	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	7.54e-05	0.00466	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—PAX6—melanoma	7.36e-05	0.00455	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—HSPA5—melanoma	7.08e-05	0.00437	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	7.02e-05	0.00434	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—UGT2B10—melanoma	6.79e-05	0.0042	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	6.72e-05	0.00415	CbGpPWpGaD
Sitagliptin—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	6.68e-05	0.00413	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	6.48e-05	0.00401	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	6.47e-05	0.004	CbGpPWpGaD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	6.03e-05	0.00372	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CTLA4—melanoma	5.93e-05	0.00366	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	5.81e-05	0.00359	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	5.74e-05	0.00355	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	5.73e-05	0.00354	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	5.47e-05	0.00338	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	5.42e-05	0.00335	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	5.38e-05	0.00333	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ACER3—melanoma	5.31e-05	0.00328	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	5.26e-05	0.00325	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	5.19e-05	0.00321	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	5.01e-05	0.0031	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	4.83e-05	0.00298	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	4.83e-05	0.00298	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CD86—melanoma	4.7e-05	0.0029	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	4.69e-05	0.0029	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL10—melanoma	4.61e-05	0.00285	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	4.48e-05	0.00277	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL4—melanoma	4.48e-05	0.00277	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	4.46e-05	0.00276	CbGpPWpGaD
Sitagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	4.43e-05	0.00273	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—PDGFRA—melanoma	4.41e-05	0.00273	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—HLA-B—melanoma	4.38e-05	0.00271	CbGpPWpGaD
Sitagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	4.37e-05	0.0027	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	4.33e-05	0.00267	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	4.32e-05	0.00267	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS2—melanoma	4.3e-05	0.00266	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—FASLG—melanoma	4.28e-05	0.00265	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	4.26e-05	0.00263	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP17A1—melanoma	4.22e-05	0.00261	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MMP1—melanoma	4.19e-05	0.00259	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP17A1—melanoma	4.16e-05	0.00257	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—FAS—melanoma	4.13e-05	0.00255	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	4.1e-05	0.00254	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	4.08e-05	0.00252	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—HLA-A—melanoma	4.06e-05	0.00251	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	4.03e-05	0.00249	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	3.99e-05	0.00247	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	3.71e-05	0.00229	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	3.61e-05	0.00223	CbGpPWpGaD
Sitagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	3.59e-05	0.00222	CbGpPWpGaD
Sitagliptin—CYP2C8—Biological oxidations—CYP1B1—melanoma	3.55e-05	0.00219	CbGpPWpGaD
Sitagliptin—CYP2C8—Metapathway biotransformation—CYP1B1—melanoma	3.5e-05	0.00216	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CD80—melanoma	3.43e-05	0.00212	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—IGF1—melanoma	3.35e-05	0.00207	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MMP2—melanoma	3.24e-05	0.002	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	3.22e-05	0.00199	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP8—melanoma	3.19e-05	0.00197	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	3.05e-05	0.00189	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	2.94e-05	0.00182	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	2.76e-05	0.0017	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IFNG—melanoma	2.71e-05	0.00167	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CXCL8—melanoma	2.69e-05	0.00166	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CUBN—melanoma	2.69e-05	0.00166	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	2.67e-05	0.00165	CbGpPWpGaD
Sitagliptin—CYP3A4—Tryptophan metabolism—MDM2—melanoma	2.56e-05	0.00158	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CXCL8—melanoma	2.52e-05	0.00156	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.51e-05	0.00155	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CTNNB1—melanoma	2.49e-05	0.00154	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP3—melanoma	2.41e-05	0.00149	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—IL2—melanoma	2.41e-05	0.00149	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	2.4e-05	0.00148	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ACER3—melanoma	2.37e-05	0.00146	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	2.36e-05	0.00146	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP17A1—melanoma	2.26e-05	0.0014	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	2.25e-05	0.00139	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	2.23e-05	0.00138	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	2.2e-05	0.00136	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	2.18e-05	0.00135	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—UGT2B10—melanoma	2.16e-05	0.00134	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	2.16e-05	0.00133	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.14e-05	0.00132	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	2.11e-05	0.00131	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	2.08e-05	0.00128	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ACER3—melanoma	2.06e-05	0.00127	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—melanoma	2.05e-05	0.00126	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	2.04e-05	0.00126	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HS3ST5—melanoma	2.01e-05	0.00124	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	2e-05	0.00123	CbGpPWpGaD
Sitagliptin—CYP3A4—Biological oxidations—CYP1B1—melanoma	1.91e-05	0.00118	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	1.9e-05	0.00117	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—UGT2B10—melanoma	1.89e-05	0.00117	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	1.88e-05	0.00116	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	1.8e-05	0.00111	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.79e-05	0.00111	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TNF—melanoma	1.75e-05	0.00108	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HS3ST5—melanoma	1.75e-05	0.00108	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	1.69e-05	0.00104	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	1.67e-05	0.00103	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.62e-05	0.001	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	1.57e-05	0.000972	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	1.55e-05	0.000955	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PLCB4—melanoma	1.53e-05	0.000942	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	1.51e-05	0.000932	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	1.5e-05	0.000925	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	1.49e-05	0.000923	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIP4K2A—melanoma	1.43e-05	0.000886	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC6A11—melanoma	1.43e-05	0.000886	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.42e-05	0.000878	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTAP—melanoma	1.4e-05	0.000862	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.36e-05	0.000842	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.35e-05	0.000834	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.33e-05	0.000822	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PLCB4—melanoma	1.33e-05	0.000821	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.31e-05	0.00081	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.28e-05	0.000792	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ACER3—melanoma	1.27e-05	0.000785	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIP4K2A—melanoma	1.25e-05	0.000772	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC6A11—melanoma	1.25e-05	0.000772	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PHGDH—melanoma	1.24e-05	0.000768	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—LUM—melanoma	1.24e-05	0.000768	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.22e-05	0.000754	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HPSE—melanoma	1.22e-05	0.000753	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTAP—melanoma	1.22e-05	0.000751	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.21e-05	0.00075	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CUBN—melanoma	1.2e-05	0.00074	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.19e-05	0.000735	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—UGT2B10—melanoma	1.16e-05	0.000718	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.16e-05	0.000716	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SDHD—melanoma	1.16e-05	0.000714	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CSPG4—melanoma	1.16e-05	0.000714	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—BSG—melanoma	1.16e-05	0.000714	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.15e-05	0.000709	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.12e-05	0.000692	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GPAM—melanoma	1.12e-05	0.000692	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.12e-05	0.000691	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.11e-05	0.000688	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—LUM—melanoma	1.08e-05	0.000669	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PHGDH—melanoma	1.08e-05	0.000669	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HS3ST5—melanoma	1.08e-05	0.000667	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HPSE—melanoma	1.06e-05	0.000656	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CUBN—melanoma	1.04e-05	0.000644	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.01e-05	0.000624	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BSG—melanoma	1.01e-05	0.000622	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SDHD—melanoma	1.01e-05	0.000622	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CSPG4—melanoma	1.01e-05	0.000622	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GPAM—melanoma	9.75e-06	0.000603	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	9.55e-06	0.00059	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PLA2G6—melanoma	9.52e-06	0.000588	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	9.29e-06	0.000574	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	9.09e-06	0.000562	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	9.09e-06	0.000562	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	8.65e-06	0.000535	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	8.59e-06	0.00053	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—VCAN—melanoma	8.55e-06	0.000528	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PLA2G6—melanoma	8.29e-06	0.000512	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PLCB4—melanoma	8.19e-06	0.000506	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.09e-06	0.0005	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	7.89e-06	0.000487	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.81e-06	0.000483	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC6A11—melanoma	7.7e-06	0.000476	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIP4K2A—melanoma	7.7e-06	0.000476	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	7.63e-06	0.000471	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTAP—melanoma	7.49e-06	0.000463	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—VCAN—melanoma	7.45e-06	0.00046	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP17A1—melanoma	7.21e-06	0.000446	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.12e-06	0.00044	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	7.02e-06	0.000434	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GNA11—melanoma	6.81e-06	0.000421	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—LUM—melanoma	6.67e-06	0.000412	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PHGDH—melanoma	6.67e-06	0.000412	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—FASN—melanoma	6.67e-06	0.000412	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC5A5—melanoma	6.56e-06	0.000405	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HPSE—melanoma	6.54e-06	0.000404	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.44e-06	0.000398	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CUBN—melanoma	6.42e-06	0.000397	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GNAQ—melanoma	6.33e-06	0.000391	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CD44—melanoma	6.33e-06	0.000391	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP17A1—melanoma	6.28e-06	0.000388	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SDHD—melanoma	6.2e-06	0.000383	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CSPG4—melanoma	6.2e-06	0.000383	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BSG—melanoma	6.2e-06	0.000383	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.2e-06	0.000383	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.14e-06	0.00038	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1B1—melanoma	6.07e-06	0.000375	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPAM—melanoma	6.01e-06	0.000371	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GNA11—melanoma	5.94e-06	0.000367	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	5.82e-06	0.00036	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—FASN—melanoma	5.81e-06	0.000359	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC5A5—melanoma	5.71e-06	0.000353	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GNAQ—melanoma	5.52e-06	0.000341	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CD44—melanoma	5.52e-06	0.000341	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.36e-06	0.000331	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1B1—melanoma	5.29e-06	0.000327	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PLA2G6—melanoma	5.11e-06	0.000316	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCB1—melanoma	5e-06	0.000309	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PRKCA—melanoma	4.6e-06	0.000284	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—VCAN—melanoma	4.59e-06	0.000284	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ERCC2—melanoma	4.56e-06	0.000282	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PRKCA—melanoma	4.01e-06	0.000248	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ERCC2—melanoma	3.98e-06	0.000246	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP17A1—melanoma	3.87e-06	0.000239	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.78e-06	0.000234	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GNA11—melanoma	3.66e-06	0.000226	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CG—melanoma	3.6e-06	0.000223	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FASN—melanoma	3.58e-06	0.000221	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC5A5—melanoma	3.52e-06	0.000217	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARG—melanoma	3.48e-06	0.000215	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GNAQ—melanoma	3.4e-06	0.00021	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CD44—melanoma	3.4e-06	0.00021	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1B1—melanoma	3.26e-06	0.000201	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CD—melanoma	3.17e-06	0.000196	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CG—melanoma	3.14e-06	0.000194	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALB—melanoma	3.13e-06	0.000193	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARG—melanoma	3.03e-06	0.000187	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CB—melanoma	2.76e-06	0.000171	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CD—melanoma	2.76e-06	0.000171	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—melanoma	2.74e-06	0.000169	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALB—melanoma	2.73e-06	0.000168	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCB1—melanoma	2.68e-06	0.000166	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PRKCA—melanoma	2.47e-06	0.000153	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ERCC2—melanoma	2.45e-06	0.000151	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CB—melanoma	2.41e-06	0.000149	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTEN—melanoma	2.39e-06	0.000147	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—melanoma	2.38e-06	0.000147	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTEN—melanoma	2.08e-06	0.000128	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CG—melanoma	1.93e-06	0.00012	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARG—melanoma	1.87e-06	0.000115	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CD—melanoma	1.7e-06	0.000105	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—melanoma	1.68e-06	0.000104	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALB—melanoma	1.68e-06	0.000104	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CB—melanoma	1.48e-06	9.16e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—melanoma	1.47e-06	9.08e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—melanoma	1.47e-06	9.06e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKT1—melanoma	1.38e-06	8.5e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTEN—melanoma	1.28e-06	7.92e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKT1—melanoma	1.2e-06	7.4e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—melanoma	9.04e-07	5.58e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKT1—melanoma	7.38e-07	4.56e-05	CbGpPWpGaD
